CAS No. :	103890-78-4
Formula :	C₂₆H₃₃NO₆
M.W :	455.54
SMILES Code :	O=C(C1=C(C)NC(C)=C(C(OCC)=O)C1C2=CC=CC=C2/C=C/C(OC(C)(C)C)=O)OCC
Synonyms :	GX 1048; GR-43659X; Motens
MDL No. :	MFCD00865936
InChI Key :	GKQPCPXONLDCMU-CCEZHUSRSA-N
Pubchem ID :	5311217

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302
Precautionary Statements:	P280-P305+P351+P338

guinea-pig ventricular myocytes	0.1 mM	2 minutes	To investigate the inhibitory effect of Lacidipine on L-type calcium current, results showed that 0.1 mM Lacidipine reduced L-type calcium current to 66±4% of control value within 2 minutes without altering the current-voltage relationship.	Br J Pharmacol. 1997 Feb;120(4):667-75
HEK293A cells	10 ×10−6, 20×10−6, and 40×10−6 Μ	6 hours	Inhibit IDO1/2 enzymatic activity	Adv Sci (Weinh). 2025 Jan;12(3):e2409310
MDA-MB-231 cells	10 ×10−6, 20×10−6, and 40×10−6 m	24 hours	Reduce the expression of IDO1, IDO2, and TDO2	Adv Sci (Weinh). 2025 Jan;12(3):e2409310
HeLa cells	5 ×10−6, 10×10−6, 20×10−6, 40×10−6, and 80×10−6 m	24 hours	Inhibit IFN γ-induced Kyn production	Adv Sci (Weinh). 2025 Jan;12(3):e2409310
murine aortic smooth muscle cells	30 μM	1-hour pretreatment followed by 4h and 24h	To investigate the effect of Lacidipine on ELDL-induced foam cell formation in smooth muscle cells. Results showed that Lacidipine significantly inhibited ELDL-mediated foam cell formation.	Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1101-13
OVCAR5	10 μM	72 h	Assess cell viability and cell death, results showed lacidipine significantly reduced viability and induced cell death in OVCAR-5 cells	J Cheminform. 2024 Oct 7;16(1):112
ID8	10–40 μM	45 min	Measure oxygen consumption rate (OCR) and ATP production, results showed lacidipine significantly inhibited OCR and ATP production in ID8 cells in a dose-dependent manner	J Cheminform. 2024 Oct 7;16(1):112
Mouse peritoneal macrophages	1-20 μM	2-24 hours	To evaluate the inhibitory effect of Lacidipine on cholesterol esterification. Results showed that Lacidipine significantly inhibited cholesterol esterification at concentrations of 10 μM and 20 μM, reducing it to 30% and 24% of the control value, respectively.	Br J Pharmacol. 1997 Nov;122(6):1209-15
rat aortic smooth muscle cells	80pM-640pM	90 minutes	Investigation of Lacidipine's inhibitory effect on K+-induced contraction in rat aorta, with steady-state IC50 of 160pM	Br J Pharmacol. 1993 May;109(1):100-6

BALB/c mice	4T1-Luc breast cancer model	Oral	0.5 mg/kg, 1 mg/kg, 10 mg/kg, 20 mg/kg	Every 2 days for 21 days	Enhance the anti-tumor effect of chemotherapeutic agents	Adv Sci (Weinh). 2025 Jan;12(3):e2409310
New Zealand male rabbits	Hypercholesterolemic diet-induced atherosclerosis model	Oral	1, 3, 10 mg/kg/day	Once daily for two months	To evaluate the effect of Lacidipine on cholesterol esterification in the aortic arch. Results showed that Lacidipine reduced cholesterol esterification in a dose-dependent manner, with inhibition rates of 24%, 30%, and 41% at doses of 1, 3, and 10 mg/kg/day, respectively. Additionally, drug treatment reduced the total cholesterol content in the vessel wall.	Br J Pharmacol. 1997 Nov;122(6):1209-15
Rat	Rat aortic rings	In vitro organ bath	80pM-640pM	Single administration, monitored for up to 120 minutes	Evaluation of Lacidipine's inhibitory effect on vascular contraction under depolarizing conditions, showing slow and prolonged action	Br J Pharmacol. 1993 May;109(1):100-6
New Zealand White rabbits	Atherosclerotic model induced by cholesterol-rich diet	Oral (mixed with food)	1, 3, and 10 mg/kg/day	Once daily for 8 weeks	To investigate the effect of Lacidipine on atherosclerotic lesions induced by cholesterol-rich diet. Results showed that Lacidipine significantly reduced the extent of aortic fatty lesions (by 40%) at the dose of 10 mg kg-1 day-1 and dose-dependently inhibited carotid intimal hyperplasia (I/M ratios were 0.47±0.02, 0.40±0.09, and 0.32±0.02 for doses 1, 3, and 10 mg kg-1 day-1, respectively).	Br J Pharmacol. 1996 May;118(2):215-9
Salt-loaded stroke-prone spontaneously hypertensive rats (SHRSP)	Salt-loaded SHRSP model	Oral (via supplemented chow)	0.3, 1, or 3 mg/kg/day	Once daily for 6 weeks (from 8 to 14 weeks of age)	Investigated the protective effects of Lacidipine on cardiac remodeling and renin production in salt-loaded SHRSP. The lowest dose (0.3 mg/kg) restored physiological downregulation of renin by high salt, reduced left ventricular hypertrophy, and decreased mRNA levels of atrial natriuretic factor and TGF-β1. Intermediate doses reduced blood pressure and PRA, but the highest dose (3 mg/kg) increased kidney renin mRNA.	Br J Pharmacol. 2001 Dec;134(7):1516-22
Stroke-prone spontaneously hypertensive rats (SHRSP) and Wistar Kyoto rats (WKY)	Salt-loaded stroke-prone spontaneously hypertensive rats (SL-SHRSP) and control (NS-SHRSP)	Oral	0.3 mg/kg/day and 1 mg/kg/day	Once daily for 6 weeks	To investigate the effect of lacidipine on cardiac hypertrophy and endothelin-1 (ET-1) gene expression. The results showed that lacidipine dose-dependently inhibited ventricle hypertrophy and ET-1 gene overexpression in SL-SHRSP, and this effect was unrelated to changes in systolic blood pressure (SBP).	Br J Pharmacol. 1996 Jun;118(3):659-64
Beagle dogs	Healthy beagle dogs	Oral	4 mg	Single dose	To evaluate the bioequivalence of three lacidipine formulations in beagle dogs. Results showed that the Cmax and AUC of the three formulations did not meet the bioequivalence criteria in 6 beagle dogs, but achieved bioequivalence in virtual simulations with 24 beagle dogs.	Asian J Pharm Sci. 2017 Jan;12(1):98-104

NCT01587742	-		Completed	-	-
NCT00460915	Hypertension	Phase 4	Completed	-	Korea, Republic of ... More >> Korea University Guro Hospital Seoul, Korea, Republic of, 152-703 Less <<
NCT02218684	Healthy	Phase 1	Completed	-	-
NCT02240641	-		Terminated	-	-
NCT02232607	Angina Pectoris	Phase 2	Completed	-	-
NCT00533858	Hypertension	Phase 4	Unknown	September 2008	Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Kyeonggi, Korea, Republic of, 463-707 Contact: Cheol-Ho Kim, MD, PhD 82-31-787-7001 cheolkim@snu.ac.kr Less <<
NCT02235402	Hypertension	Phase 4	Completed	-	-
NCT02264158	Healthy	Phase 1	Completed	-	-
NCT02203500	Healthy	Phase 1	Completed	-	-
NCT02209649	Healthy	Phase 1	Completed	-	-
NCT02235415	-		Completed	-	-
NCT00338338	Uncomplicated Hypertension ... More >> Hypertension Essential Less <<	Phase 4	Completed	-	Taiwan ... More >> GSK Investigational Site Taipei, Taiwan, 100 Less <<
NCT00328965	Diabetes Mellitus, Type 2\|Esse... More >>ntial Hypertension Less <<	PHASE4	COMPLETED	2025-05-06	-
NCT02177331	Hypertension	PHASE3	COMPLETED	-	-

{[proInfo.proName]}

CAS No.: 103890-78-4

{[proInfo.proName]}

CAS No.: 103890-78-4

Product Citations

Alternative Products

Product Details of Lacidipine

Safety of Lacidipine

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	2.20mL 0.44mL 0.22mL	10.98mL 2.20mL 1.10mL	21.95mL 4.39mL 2.20mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed